Table: Kaken Pharmaceutical -2025/26 group forecast

KAKEN PHARMACEUTICAL

22/04/2026 07:30

Apr 22 (Reuters) -
              Kaken Pharmaceutical Co Ltd     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2026      Mar 31, 2026   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales            76.90             86.30      
  Operating    loss 900 mln           2.10      
  Recurring    loss 200 mln           2.80      
  Net               2.10              2.30      
  EPS            55.39 yen         60.74 yen    
 
  NOTE - Kaken Pharmaceutical Co Ltd.    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T